|Bid||0.2900 x 0|
|Ask||0.3000 x 0|
|Day's Range||0.2900 - 0.3050|
|52 Week Range||0.2850 - 1.8300|
|Beta (3Y Monthly)||1.09|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VANCOUVER, British Columbia , June 13, 2019 /CNW/ -- MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (OTCBB: MYMMF) ("MYM" or "The Company") Is pleased to announce it will begin ...
VANCOUVER, British Columbia, June 11, 2019 /CNW/ -- MYM Nutraceuticals Inc. ("MYM" or "The Company") (CSE:MYM.CN - News) (MYM.CN) (CSE:MYM.CN - News) (OTCBB:MYMMF - News) is pleased to announce that it has commitments totaling $9.5 million in financing, which will fully fund its strategic plan through 2020. The $9.5 million is a mixture of $5.5 million of debt from Trichome Financial Corp ("Trichome Financial" or "Trichome") and $4 million of equity from Alumina Partners LLC ("Alumina Partners"). "MYM is encouraged to share that, after considerable due diligence, Trichome Financial and Alumina Partners have decided to provide the company with commitments to finance up to $9.5 million," said Howard Steinberg, CEO of MYM.
VANCOUVER, British Columbia , June 8, 2019 /CNW/ -- MYM Nutraceuticals Inc., (CSE: MYM.CN) (CSE: MYM) (OTCBB: MYMMF) ("MYM" or "The Company") announces it has closed a non-brokered ...
Thanks to a trending new use as a tobacco substitute cannabidiol (CBD) sales are exploding across Europe. ...